Intellectual Disability
|
0.310 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Thus, ACTL6A gene mutation analysis should be considered in patients with intellectual disability, learning disabilities, or developmental language disorder.
|
28649782 |
2017 |
Intellectual Disability
|
0.310 |
GeneticVariation
|
group |
BEFREE |
Thus, ACTL6A gene mutation analysis should be considered in patients with intellectual disability, learning disabilities, or developmental language disorder.
|
28649782 |
2017 |
Developmental delay (disorder)
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability.
|
28649782 |
2017 |
Global developmental delay
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability.
|
28649782 |
2017 |
Spina Bifida Cystica
|
0.200 |
Biomarker
|
disease |
RGD |
miR-9*- and miR-124a-Mediated switching of chromatin remodelling complexes is altered in rat spina bifida aperta.
|
23677776 |
2013 |
Atrial Septal Defects
|
0.100 |
GeneticVariation
|
group |
CLINVAR |
|
|
|
Hernia, Inguinal
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Umbilical hernia
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Syncope
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Torticollis
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Broad nasal tip
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Broad thumbs
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Delayed speech and language development
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Recurrent otitis media
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Coarse facial features
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Aplasia/Hypoplasia of the nails
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Cleft anterior mitral valve leaflet
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Acid reflux
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Neoplasm Metastasis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
ACTL6A-overexpression and ACTL6A-knockdown colon cancer cells were used to perform cytological experiments to explore the potential biological function of ACTL6A in metastasis and EMT in colon cancer.
|
30348114 |
2018 |
Tumor Cell Invasion
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
ACTL6A overexpression promoted migration and invasion of colon cancer cells, whereas ACTL6A knockdown exhibited the opposite effect in vitro.
|
30348114 |
2018 |
Neoplasm Metastasis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
In conclusion, data from the present study demonstrated that ACTL6A was associated with poor survival and promoted osteosarcoma cell metastasis through EMT, suggesting that ACTL6A may be a novel prognostic biomarker and therapeutic target for osteosarcoma.
|
28260090 |
2017 |
Tumor Cell Invasion
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
Both in vitro and in vivo assays showed that ACTL6A overexpression promoted osteosarcoma cell invasion and metastasis, whereas knockdown of ACTL6A expression reduced osteosarcoma cell malignant behavior such as invasion and metastasis.
|
28260090 |
2017 |
Tumor Cell Invasion
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Further functional analysis indicated that BAF53a overexpression could promote proliferation and increase the motility and invasion of U87 glioma cells, whereas BAF53a knockdown had the opposite effect.
|
29039584 |
2017 |
Neoplasm Metastasis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Mechanistically, ACTL6A promotes metastasis and EMT through activating Notch signaling.
|
26698646 |
2016 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
However, the roles of ACTL6A in the development of ovarian cancer and the regulation of cancer glucose metabolism are mostly unknown.
|
31649264 |
2019 |